Atrejo Patridge, NP

Atrejo Patridge practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Atrejo Patridge's NPI, 1841745411, was assigned on August 23, 2016. Atrejo Patridge holds California license 95004769.

Atrejo Patridge's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Atrejo Patridge's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Atrejo Patridge is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Atrejo Patridge to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Atrejo Patridge practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Atrejo Patridge's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Atrejo Patridge is licensed in California.

Dmand AI lists acute skin infection, anxiety, asthma, chronic diabetes, conjunctivitis, contact dermatitis, ear eustachian tube disorders and enthesopathy in foot or ankle among the conditions Atrejo Patridge treats.

CMS data shows 689 Medicare services from Atrejo Patridge across 6 procedure codes in 2024, for 374 Medicare patients. Medicare paid $29,950 for them. Every service was in an office.

CMS counts 374 Medicare patients who saw Atrejo Patridge in 2024. The largest group is 65 to 74, with 135 patients. 67% of them have high blood pressure, and 67% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Atrejo Patridge's median patient age at 73, with 61% women.

In 2024, Atrejo Patridge wrote 1,560 Medicare Part D claims for 597 patients. 83% of them were for generic drugs. CMS names the drug for 959 of them, across 41 drugs with 11 or more claims each, at $94,400 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Atrejo Patridge for performance year 2024, reported as part of a group. Atrejo Patridge accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Atrejo Patridge as offering telehealth.